. . "156-162" . "Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication"@en . . . . . . . . . . "Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication"@en . "10.1016/S0360-3016(02)02915-2" . "Stella Y Tsai" . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en setiembre de 2002"@ast . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0443 \u0432\u0435\u0440\u0435\u0441\u043D\u0456 2002"@uk . . . . "Cheng-Fang Horng" . "Jason Chia-Hsien Cheng" . . "James Jer-Min Jian" . . . "Chao-Ming Huang" . "Skye Honguin Cheng" . "1" . . "Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication"@en . . "Yu-Mong Lin" . "2002-09-01T00:00:00Z"^^ . . "12182986" . "article scientifique publi\u00E9 en 2002"@fr . "Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication"@nl . . . . "wetenschappelijk artikel"@nl . "Hua-Shan Liu" . . . . . . . . . "Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication"@en . . "scientific article published on 01 September 2002"@en . . "Tsun-I Cheng" . . . . "54" . . . . . . . . . . . . "Jian-Kuen Wu" . "Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication"@nl . . . . . . . . . . "David Y Huang" . . . . . . . . . . . . . . . "Andrew T Huang" . . . . . . . "im September 2002 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . "Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication"@nl . .